Dewpoint Therapeutics: Funding, Investors & Team (Oct 2026)
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine for genetically linked condensatopathy which is a collection of engineered cell lines with trackable condensates to prevent harmful protein sequestration, helping healthcare providers to have access to new therapies to address unmet needs. The company was founded in 2018 and is headquartered in Boston, Massachusetts.
Dewpoint Therapeutics has raised $150M across 2 funding rounds on record, the most recent a Series D announced in Sep 2025.
Dewpoint Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2025.
Dewpoint Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Dewpoint Therapeutics raised $150M in a Series C announced in Feb 2022.
3.6 years later, a Series D was announced in Sep 2025 with no disclosed amount.
Dewpoint Therapeutics Founders and Leadership Team
Contact details for the Dewpoint Therapeutics team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Dewpoint Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like Dewpoint Therapeutics in Biotechnology and Boston
Companies Similar to Dewpoint Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Dewpoint Therapeutics Funding FAQs
What does Dewpoint Therapeutics do?
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine for genetically linked condensatopathy which is a collection of engineered cell lines with trackable condensates to prevent harmful protein sequestration, helping healthcare providers to have access to new therapies to address unmet needs. The company was founded in 2018 and is headquartered in Boston, Massachusetts.
How much funding has Dewpoint Therapeutics raised?
Dewpoint Therapeutics has raised $150M across 2 rounds on record.
When did Dewpoint Therapeutics last raise funding?
Dewpoint Therapeutics' most recent funding round on record was announced in Sep 2025. The amount was not disclosed.
Who is the CEO of Dewpoint Therapeutics?
Sandra Kleinstück is listed as CEO at Dewpoint Therapeutics.
Where is Dewpoint Therapeutics headquartered?
Dewpoint Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Dewpoint Therapeutics have?
Dewpoint Therapeutics is in the 101-250 employee band.
About FundedIQ's Dewpoint Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dewpoint Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.